Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 18Colorectal Neoplasms 16Breast Neoplasms 10Pancreatic Neoplasms 6Colonic Neoplasms 6Stomach Neoplasms 5Neoplasm Metastasis 4Gallbladder Neoplasms 3Bile Duct Neoplasms 3Uterine Cervical Neoplasms 2Somatostatinoma 2Esophageal Neoplasms 2Anus Neoplasms 2Anal Canal Carcinoma 2Adenoma, Islet Cell 2Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Ovarian Neoplasms 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Lung Neoplasms 1Liver Neoplasms 1Kidney Neoplasms 1Insulinoma 1Inflammatory Breast Neoplasms 1Glucagonoma 1Gastro Oesophageal Cancer 1Gastrinoma 1Erythema Multiforme 1Central Nervous System Neoplasms 1

Interventions

Capecitabine 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Erythema Multiforme × Capecitabine × Clear all
NCT00671645 2020-10-19

Preoperative Combined RadioChemo-Molecular Target Therapy With Capecitabine, Bevacizumab, and Radiotherapy

Austrian Breast & Colorectal Cancer Study Group

Phase 2 Terminated
8 enrolled
Gastrointestinal

Carcinoma, Erythema Multiforme, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡